ID
32344
Beskrivning
Study ID: 109563 Clinical Study ID: 109563 Study Title: COMPAS:A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier https://clinicaltrials.gov/ct2/show/NCT00466947 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Trade Name: BIO 10PN-PD-DIT; Synflorix Study Indication: Infections, Streptococcal The Study consists of three workbooks. Workbook 1: Argentina, all subjects + immuno & reacto subset Workbook 2: Panama, all subjects + immuno & reacto subset + carriage subset + additional immuno subset Workbook 3: Colombia, all subjects The protocol number for all workbooks: 109563 (10Pn-PD-DiT-028) There are ten visits in workbook 1 and 2, eight for workbook 3 (there are no visits 4 and 7): Visit 1: month 0, dose 1, 6-16 weeks of age Visit 2: month 2, dose 2, +/- 4 months of age, 49-83 days after visit 1 Visit 3: month 4, dose 3, +/- 6 months of age, 49-83 days after visit 2 Visit 4: month 5, +/- 7 months of age, 28-42 days after visit 3. Only for immuno & reacto subset + carriage subset. Visit 5: month 10-13, 12-15 months of age Visit 6: month 13-16, booster dose, 15-18 months of age, ≥ 28 days after visit 5 Visit 7: month 14-17, 16-19 months of age, 28-42 days after visit 6. Only for immuno & reacto subset, additional immuno subset + carriage subset. Visit 8: month 16-19, 18-21 months of age, ≥ 28 days after visit 6 Visit 9: month 22-25, 24-27 months of age Visit 10: Contact This document contains the non-serious adverse events form. It has to be filled in if non-serious adverse event occurs during study. It's for all workbooks.
Länk
https://clinicaltrials.gov/ct2/show/NCT00466947
Nyckelord
Versioner (3)
- 2018-10-26 2018-10-26 -
- 2018-10-27 2018-10-27 -
- 2018-10-27 2018-10-27 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
27 oktober 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Vaccination against pneumonia and otitis media, NCT00466947
Non-serious adverse events
- StudyEvent: ODM
Similar models
Non-serious adverse events
- StudyEvent: ODM
C0011008 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C1298908 (UMLS CUI [2,1])
C2368628 (UMLS CUI [2,2])
C0545082 (UMLS CUI [3,1])
C1272696 (UMLS CUI [3,2])
C1518404 (UMLS CUI [1,2])
C0450429 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0231291 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0085978 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C1386497 (UMLS CUI [1,2])
C1386497 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C0008961 (UMLS CUI [1,2])